Viracor-IBT is one of the first laboratories in the United States dedicated to serving the distinctive needs of transplant patients. Our commitment to the discipline of bone marrow and solid organ transplantation is the foundation of our company’s vision - to be the leading provider of molecular and immune-diagnostic testing services. Our specialized menu of molecular viral and bacterial testing, in addition to fungal screening and immunology assays, offer the clinician essential laboratory diagnostics useful for patient assessment throughout the transplant process, such as in patients undergoing hematopoietic stem cell transplantation (HSCT).
We know that clinically meaningful results, available when the physician needs them, are critical to transplant patient outcomes, and this is why we offer some of the fastest turnaround times available for quantitative PCR testing of many critical pathogens which affect the transplant population, including CMV qPCR, BKV qPCR, HHV6 qPCR and EBV qPCR. Our quantitative PCR tests are resulted the same day we receive the specimen, and CMV antiviral resistance is resulted in 2 to 3 days compared with an approximate industry average of 14 to 21 days. Our unsurpassed delivery of diagnostic lab results coupled with excellence in customer service and science are why many of our nation's pediatric transplant hospitals, academic medical centers and transplant hospitals have partnered with Viracor-IBT to meet their critical transplant program testing needs.
To learn more about the specific tests we offer, search under the Transplantation specialty in the Test Menu.